Search research articles
Contact Us
Filters
Showing results (81-90 of 265) with videos related to
Page
of 27
Sort By:
Biochemistry
|
March 11, 1975
Productive and unproductive lysozyme-chitosaccharide complexes. Equilibrium measurements
E Holler, J A Rupley, G P Hess
Biochemistry
|
June 3, 1975
Productive and unproductive lysozyme-chitosaccharide complexes. Kinetic investigations
E Holler, J A Rupley, G P Hess
Scientific Reports
|
March 15, 2020
Object responses are highly malleable, rather than invariant, with changes in object appearance
Desiree E Holler, Sara Fabbri, Jacqueline C Snow
Blut
|
February 1, 1986
Successful treatment with high-dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII
E Hiller, E Holler, R G Geursen, et al.
Thrombosis Research
|
May 15, 1992
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT)
C Seeber, E Hiller, E Holler, et al.
Biochemical and Biophysical Research Communications
|
August 21, 1973
Phenylalanyl-tRNA synthetase from E. coli: synergistic coupling between the sites for binding of L-phenylalanine and ATP
E Holler, P Bartmann, T Hanke, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
October 1, 1972
[Isoleucyl-tRNA-synthetase: inhibition of isoleucyladenylate synthesis due to spermine]
E Holler, P Bartmann, T Hanke, et al.
European Journal of Biochemistry
|
August 10, 2000
Synthetic substrates and inhibitors of beta-poly(L-malate)-hydrolase (polymalatase)
B Gasslmaier, C M Krell, D Seebach, et al.
Lancet (London, England)
|
October 23, 1993
Monitoring of veno-occlusive disease after bone-marrow transplantation by serum aminopropeptide of type III procollagen
C Salat, E Holler, H J Kolb, et al.
Der Internist
|
June 1, 1989
[Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)]
G Jung, E Holler, H J Kolb, et al.
Page
of 27
Search research articles
Search
Showing results (81-90 of 265) with videos related to
Sort By:
Page
of 27
Biochemistry
|
March 11, 1975
Productive and unproductive lysozyme-chitosaccharide complexes. Equilibrium measurements
E Holler, J A Rupley, G P Hess
Biochemistry
|
June 3, 1975
Productive and unproductive lysozyme-chitosaccharide complexes. Kinetic investigations
E Holler, J A Rupley, G P Hess
Scientific Reports
|
March 15, 2020
Object responses are highly malleable, rather than invariant, with changes in object appearance
Desiree E Holler, Sara Fabbri, Jacqueline C Snow
Blut
|
February 1, 1986
Successful treatment with high-dose intravenous immunoglobulin in a patient with spontaneous inhibitor to factor VIII
E Hiller, E Holler, R G Geursen, et al.
Thrombosis Research
|
May 15, 1992
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT)
C Seeber, E Hiller, E Holler, et al.
Biochemical and Biophysical Research Communications
|
August 21, 1973
Phenylalanyl-tRNA synthetase from E. coli: synergistic coupling between the sites for binding of L-phenylalanine and ATP
E Holler, P Bartmann, T Hanke, et al.
Hoppe-Seyler'S Zeitschrift Fur Physiologische Chemie
|
October 1, 1972
[Isoleucyl-tRNA-synthetase: inhibition of isoleucyladenylate synthesis due to spermine]
E Holler, P Bartmann, T Hanke, et al.
European Journal of Biochemistry
|
August 10, 2000
Synthetic substrates and inhibitors of beta-poly(L-malate)-hydrolase (polymalatase)
B Gasslmaier, C M Krell, D Seebach, et al.
Lancet (London, England)
|
October 23, 1993
Monitoring of veno-occlusive disease after bone-marrow transplantation by serum aminopropeptide of type III procollagen
C Salat, E Holler, H J Kolb, et al.
Der Internist
|
June 1, 1989
[Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)]
G Jung, E Holler, H J Kolb, et al.
Page
of 27